Mohammed Samy, Head of Supply Chain at Pharmanovia looks to answer the question how can we future proof value chains to build resilience and agility without compromising our ESG efforts?
As we move into 2024, life sciences real estate managers will need to consider sustainability, funding, investor consolidation, and planning regulations as top priorities.
In this article, Dr Julian Northen, Solid State Manager at Onyx Scientific, explores the challenges associated with achieving sustainability in pharma and the solutions the industry must adopt to ensure alignment with global goals and regulations.
Julie Neal, Director at management consultancy, Vendigital, and Dr. Ulli Waltinger, Vice President specialising in AI and IoT at Siemens Advanta explore Life Sciences: A Data-Led Approach to Sustainability Transformation.
Baljit Bhogal, Building Services and Sustainability Consultant, Margaret McDevitt, Sustainability Engineer and Geoff Brock, Director of Sustainability, all at IPS-Integrated Project Services Ltd explore balancing health and the environment.
Robert Newman, Chief Scientific Officer at FUJIFILM Irvine Scientific and Tom Fletcher, Director of Research and Development at FUJIFILM Irvine Scientific explore ways of optimising bioprocessing workflows.
Dr Torill Bigg, Chief Carbon Reduction Scientist, Tunley Environmental explores scope 3 and how it can be the largest part by far of an organisation’s carbon footprint, and not all of them can justly be laid at the foot of the supply chain.
Responsible Manufacturing Can Help Curb Drug Resistance: New report sets out clear steps pharmaceutical companies should take to limit AMR risk in antibiotic production.
Rex Clements, CEO at Centrient Pharmaceuticals, sheds light on the company’s efforts to contribute to a more sustainable global supply chain for antibiotics.
Mike Hook, Sales & Marketing Director for PRAB, explores how wastewater recycling is a pathway to lower risk exposure and water costs in pharmaceutical manufacturing.
